MedTrace Logo

A Trial of Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian Cysts

NCT05293574 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2022-03-24

No results posted yet for this study

Summary

To compare the effectiveness of (norethisterone acetate) in the treatment of spontaneously occurring simple ovarian cyst detected by ultrasonography compared with expectant management.

Conditions

  • Ovarian Cyst Simple

Interventions

DRUG

norethisterone acetate

Norethindrone, a progesterone agonist

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • abobakr alsokary abbas, prof.dr · assiut

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
24 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-10-01
Completion
2023-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05293574 on ClinicalTrials.gov